Neuromuscular Monitoring of Rocuronium 0.6 mg/kg in Children Aged 3–24 Months With Electromyography and Acceleromyography: An Observational Study - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Assessment of Neuromuscular Function Following Rocuronium Administration (0.6 mg/kg) in Pediatric Patients Aged 3 to 24 Months Using Electromyography and Acceleromyography: An Observational Analysis

  • By

  • Sarah Sofie Wadland

  • Karl Peter Damgård Madsen

  • Mikkel Helmuth Jensen

  • Magnus Fuhr Hovind

  • Morten Sonne

  • Morten Bøttger

  • Arash Afshari

  • Frederik Mondrup

  • Matias Vested

  • May 19, 2026

Share

Original Source(s)

Neuromuscular Monitoring of Rocuronium 0.6 mg/kg in Children Aged 3–24 Months With Electromyography and Acceleromyography: An Observational Study

  • by Sarah Sofie Wadland, Karl Peter Damgård Madsen, Mikkel Helmuth Jensen, Magnus Fuhr Hovind, Morten Sonne, Morten Bøttger, Arash Afshari, Frederik Mondrup, Matias Vested

  • May 19, 2026

Related Content

Pediatric tularemia in Denmark: a forgotten disease

Error in Table 2 Footnote

  • September 1, 2026

Top 10 evidence-based essentials in pediatrics

A structured framework of guidelines, trials, therapies, and clinical tools used in pediatric practice.